Advertisement

Schizophrenia and the Metabolic Syndrome

  • Jared Edward Reser
Chapter

Abstract

Individuals with schizophrenia are at a high risk of developing life-shortening illnesses and are especially prone to developing metabolic diseases. Epidemiological evidence has demonstrated that schizophrenia is closely associated with the metabolic syndrome and its associated disorders, including type 2 diabetes mellitus, cardiovascular disease, dyslipidemia, visceral fat distribution, and hypertension. This association has been attributed to behavioral factors seen in patients with schizophrenia like poor diet, increased food intake, increased dietary fat content, lack of exercise, and reduced physical activity but there are clearly other mediating factors. Specific features of the metabolic syndrome are known to be exacerbated by severe stress and elevated levels of cortisol, elements common in schizophrenia. The antipsychotic medications widely prescribed in schizophrenia, especially the atypical antipsychotics, have been implicated in the onset and worsening of metabolic symptoms. There is also evidence pointing towards the fact that schizophrenia and the metabolic syndrome present comorbidly because of a shared genetic basis. The public health significance of these associations is clear and provides impetus for mental health professionals to become more responsible for identifying, treating, and monitoring the physical symptoms of schizophrenia in addition to the psychiatric ones. Unfortunately, health care practitioners may not place enough emphasis on the treatment of metabolic disorders in this population because of low awareness and past ambiguity of findings.

Keywords

Metabolic Syndrome Antipsychotic Drug Atypical Antipsychotic Antipsychotic Medication Excess Mortality 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

References

  1. Allebeck P. Schizophrenia Bull. 1989;15:81–9.Google Scholar
  2. Allison DB, Fontaine KR, Heo M. J Clin Psychiat. 1999;60:215–20.CrossRefGoogle Scholar
  3. American Diabetes Association, American Psychiatric Association, American Association of Clinical Endocrinologists, North American Association for the Study of Obesity. J Clin Psychiat. 2004;65:267–72.CrossRefGoogle Scholar
  4. Basu R, Brar JS, Chengappa KNR, John V, Parepally H, Gershon S, Schlicht P, Kupfer D. Bipolar Disord. 2004;6:314–8.PubMedCrossRefGoogle Scholar
  5. Bhugra D. PLoS Med. 2006;2:372–3.Google Scholar
  6. Brown S. Brit J Psychiatry. 1997;171:502–508CrossRefGoogle Scholar
  7. Brown S, Birtwistle J, Roe L, Thompson C. Psychol Med. 1999;29:697–701.PubMedCrossRefGoogle Scholar
  8. Cohn T, Prud’homme D, Steiner D, Kameh H, Remington G. Can J Psychiat. 2004;49:753–60.Google Scholar
  9. Davidson M. J Clin Psychiat. 2002;63:5–11.Google Scholar
  10. De Hert M, van Eyck D, De Nayer A. Int Clin Psychopharmacol. 2006;21:S11–5.PubMedCrossRefGoogle Scholar
  11. De Leon J, Diaz FJ. Schizophr Res. 2007;96:185–97.PubMedCrossRefGoogle Scholar
  12. Dixon L, Weiden P, Delahanty J, Goldberg R, Postrado L, Lucksted A, Lehman A. Schizophrenia Bull. 2000;26:903–12.Google Scholar
  13. Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults. JAMA. 2001;285:2486–97.CrossRefGoogle Scholar
  14. Ford ES, Giles WH. Diabetes Care. 2003;26:575–81.PubMedCrossRefGoogle Scholar
  15. Felker B, Yazel JJ, Short D. Psychiat Serv. 1996;47:1356–63.Google Scholar
  16. Gothelf D, Falk B, Singer P. Am J Psychiat. 2002;159:1055–7.PubMedCrossRefGoogle Scholar
  17. Hannerz H, Borgå P, Borritz M. Public Health. 2001;115:32837.CrossRefGoogle Scholar
  18. Hansen BC. Ann NY Acad Sci. 1999;829:1–24.CrossRefGoogle Scholar
  19. Haupt DW. Eur Neuropsychopharmacol. 2006;16:S149–55.PubMedCrossRefGoogle Scholar
  20. Heiskanen T, Niskanen L, Lyytikainen R, Saarinen PI, Hintikka J. J Clin Psychiat. 2003;64:575–9.CrossRefGoogle Scholar
  21. Hert MD, Schreurs V, Sweers K, Van Eyck D, Hanssens L, Sinko S, Wampers M, Scheen A, Peuskens J, van Winkel R. Schizophrenia Res. 2008;101:295–303.CrossRefGoogle Scholar
  22. Homel P, Casey D, Allison DB. Schizophrenia Res. 2002;55:277–84.CrossRefGoogle Scholar
  23. Jeste DV, Gladsjo JA, Lindamer LA, Lacro JP. Schizophrenia Bull. 1996;22:412–30.Google Scholar
  24. Kendrick T. Br J Psychiat. 1996;169:733–9.CrossRefGoogle Scholar
  25. Marder SR, Essock SM, Miller AL, Buchanan RW, Casey DE et al. Am J Psychiat. 2004;161:1334–49.Google Scholar
  26. Masterson E, O’Shea B. Brit J Psychiat. 1984;43:643–9.Google Scholar
  27. McEvoy JP, Meyer JM, Goff DC, Nasrallah HA, Davis SM, Sullivan L, Meltzer HY, Hsiao J, Stroup TS, Lieberman JA. Schizophrenia Res. 2005;80:19–32.CrossRefGoogle Scholar
  28. Meyer JM. J Clin Psychiat. 2001;62:27–34.Google Scholar
  29. Meyer JM, Nasrallah HA. Medical illness and schizophrenia.Washington, DC: American Psychiatric Press; 2003.Google Scholar
  30. Mortensen PB, Juel K. Brit J Psychiat. 1993;163:183–9.PubMedCrossRefGoogle Scholar
  31. Mukherjee S, Schnur DB, Reddy R. Lancet. 1989;1:495.PubMedCrossRefGoogle Scholar
  32. Mukherjee S, Decina P, Bocola V, Saraceni F, Scapicchio PL. Compr Psychiat. 1996;37:68–73.PubMedCrossRefGoogle Scholar
  33. Newcomer JW, Haupt DW. Can J Psychiat. 2006;51:480–91.Google Scholar
  34. Newman SC, Bland RC. Can J Psychait. 1991;36:239–45.Google Scholar
  35. Osby U, Correia N, Brandt L, Ekbom A, Sparen P. Schizophrenia Res. 2000;45:21–8.CrossRefGoogle Scholar
  36. Raphael RP. Arch Neurol Psychiat. 1921;5:687–709.Google Scholar
  37. Reser JE. Med Hypotheses. 2007;69:383–94.PubMedCrossRefGoogle Scholar
  38. Ristow M. J Mol Med. 2004;82:510–29.PubMedCrossRefGoogle Scholar
  39. Rosmond R, Bjorntorp P. J Intern Med. 2000;247:188–97.PubMedCrossRefGoogle Scholar
  40. Ryan MC, Thakore JH. Life Sci. 2002;71:239–57.PubMedCrossRefGoogle Scholar
  41. Saddichha S, Manjunatha N, Ameen S, Akhtar S. Schizophrenia Res. 2008;101:266–72.CrossRefGoogle Scholar
  42. Shirzadi AA, Ghaemi SN. Harv Rev Psychiat. 2006;14:152–64.CrossRefGoogle Scholar
  43. Spelman LM, Walsh PI, Sharifi N, Collins P, Thakore JH. Diabet Med. 2007;24:481–5.PubMedCrossRefGoogle Scholar
  44. Thakore JH, Mann JN, Vlahos I, Martin A, Reznek R. J Int Assoc Study Obesity. 2002;26:137–41.CrossRefGoogle Scholar
  45. Walker EF, Diforio D. Psychol Rev. 1997;104:667–85.PubMedCrossRefGoogle Scholar
  46. Walker EF, Neumann C, Baum KM, Davis D, Diforio D, Bergman A. Dev Psychopathol. 1996;8:647–55.CrossRefGoogle Scholar
  47. Weiser M, Knobler H, Lubin G, Nahon D, Kravitz E, Caspi A, Noy S, Knobler HY, Davidson M. J Clin Psychiat. 2004;65:1546–9.CrossRefGoogle Scholar
  48. Wirshing DA, Meyer JM. In: Meyer JM, Nasrallah H, editors. Medical illness and schizophrenia.Washington, DC: American Psychiatric Press; 2003. pp. 39–58.Google Scholar
  49. Zhang ZJ, Yao ZJ, Liu W, Fang Q, Reynolds GP. Brit J Psychiat. 2004;18:58–62.CrossRefGoogle Scholar
  50. Zimmet P, Boyko EJ, Collier GR, De Courten M. Ann NY Acad Sci. 1999;892:25–44.PubMedCrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media, LLC 2011

Authors and Affiliations

  1. 1.Psychology DepartmentUniversity of Southern CaliforniaLos AngelesUSA

Personalised recommendations